Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2024 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2024 Earnings Call Transcript November 6, 2024Vanda Pharmaceuticals Inc. beats earnings expectations.
Posts Tagged ‘NASDAQ:VNDA’
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Meg, and I will be your conference operator today.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Hermine, and I will be your conference operator today.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Jeannie and I will be your conference operator today.
What Made Laughing Water Capital Sell Vanda Pharmaceuticals (VNDA)?
Laughing Water Capital, an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Cash-Rich Penny Stocks Hedge Funds Are Buying
This article presents an overview of the 5 Cash-Rich Penny Stocks Hedge Funds Are Buying. For a detailed overview of such stocks, read our article, 15 Cash-Rich Penny Stocks...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
15 Best Affordable Stocks To Buy Under $5
In this article, we discuss 15 best affordable stocks to buy under $5.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Audra, and I will be your conference operator today.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. My name is David and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Q1 2023 Vanda Pharmaceuticals Inc.
5 Best Depressed Stocks To Buy Now
In this article, we discuss 5 best depressed stocks to buy now.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Q4 2022 Vanda Pharmaceuticals Inc. Earnings Conference Call.
15 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will take a look at 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors.
Were Hedge Funds Right About Vanda Pharmaceuticals Inc. (VNDA)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Is VNDA A Good Stock To Buy Now According To Hedge Funds?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds Taking Some Chips Off The Table
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Were Hedge Funds Right About Vanda Pharmaceuticals Inc. (VNDA)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds Sticking Around
In this article we will check out the progression of hedge fund sentiment towards Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds In Wait-and-See Mode
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Hedge Funds Have Never Been Less Bullish On Vanda Pharmaceuticals Inc. (VNDA)
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Is Vanda Pharmaceuticals Inc. (VNDA) A Good Stock To Buy?
A market surge in the first quarter, spurred by easing global macroeconomic concerns and Powell's pivot ended up having a positive impact on the markets and many hedge funds as...
Is Vanda Pharmaceuticals Inc. (VNDA) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
Vanda Pharmaceuticals Inc. (VNDA): Hedge Fund Sentiment Unchanged
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 7% during October and...
13G Filing: Armistice Capital and Vanda Pharmaceuticals Inc. (VNDA)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent...
Hedge Funds Are Betting On Vanda Pharmaceuticals Inc. (VNDA)
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.
This Biotech Hedge Fund’s Stock Picks Killed It in Q3
Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again.
Vanda Pharmaceuticals Inc. (VNDA) Stock: Deerfield Management Cashes In 2.56 Million Shares
According to a freshly-amended 13G filing with the Securities and Exchange Commission, James E.
Here’s Why Traders Are Buzzing about These Five Stocks
Fading chances of a rate hike soothed the market sentiment on Wednesday.
Vanda Pharmaceuticals Inc. (VNDA)’s Stock Jumps Following NDA Approval
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)'s shares have advanced by more than 9% after the U.S.
13G Filing: Stonepine Capital Management, LLC Details Ownership of Vanda Pharmaceuticals Inc. (VNDA)
We are seeing a lot of 13G filing activity at the moment and one of the more interesting filings is this one submitted to the SEC by Stonepine Capital.
Smart Money Is Seeing Upside For These Three Companies
According to a recent filing with the SEC, Christopher Sackelton and Adam Grey's Coliseum Capital has acquired some 2.74 million shares of Universal Technical Institute, Inc...
Are Hedge Funds Losing Interest In Vanda Pharmaceuticals Inc. (VNDA)?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their ...
These Five Biotech Stocks Ranked Among This UK-based Fund’s Favorites
Cheyne Capital is one of the few non-U.S firms that we track in our database.
Stonepine Capital Management Reveals 5.5% Stake in Vanda Pharmaceuticals Inc. (VNDA)
In a new filing with the Securities and Exchange Commission, Stonepine Capital Management disclosed a passive stake in Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday.
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): This Week in Biotech
With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Sanofi SA (ADR) (SNY), Vanda Pharmaceuticals Inc. (VNDA), Merck & Co., Inc. (MRK) – Sleep War Z: A Written History of the Insomniac War
It’s estimated that 30% to 40% of adults in the world experience some degree of insomnia every year. Most of these cases aren’t chronic and do not require medication.
Micron Technology, Inc. (MU) Calls Change Hands At A Clip Ahead of Earnings After The Close
Micron Technology, Inc. (NASDAQ:MU) – Options traders appear to be snapping up out of the money call options on Micron Technology, Inc.
Discovery Laboratories, Inc. (DSCO): Are Hedge Funds Right About This Stock?
Is Discovery Laboratories, Inc. (NASDAQ:DSCO) a healthy stock for your portfolio? Investors who are in the know are getting less optimistic.
Assessing Raptor Pharmaceutical Corp. (RPTP)’s Agreement With HealthCare Royalty Partners
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) signed an agreement with HealthCare Royalty Partners.
Bristol Myers Squibb Co (BMY), Momenta Pharmaceuticals, Inc. (MNTA): White Collar Criminals Love Biotech Stocks
It's understandably very tempting for people with inside information to trade biotech stocks.
Hedge Funds Have Bought Lamar Advertising Co (LAMR), ITT Educational Services, Inc. (ESI) & More
The most comprehensive picture of hedge fund activity comes in the form of quarterly 13F filings.
Baker Bros. Advisors Boosts Stake in Vanda Pharmaceuticals Inc. (VNDA)
In the hedge fund world, Julian Baker and Felix Baker’s Baker Bros. Advisors reported a purchase of 2,028,789 shares in Vanda Pharmaceuticals Inc.
This Metric Says You Are Smart to Buy Vanda Pharmaceuticals Inc. (VNDA)
In the 21st century investor’s toolkit, there are many indicators shareholders can use to watch the equity markets.
Avoid This Biotech Stock: Chelsea Therapeutics International Ltd. (CHTP)
Editor's note: This article is a stock pitch made by a member on CAPS, The Motley Fool's free investing community.
